|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| 18-11-13 | CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel | CI |
| 18-08-30 | Joe Pavlik Joins the Advisory Board of CaliPharms, Inc | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | - | - | - | - | - | 13.88K | ||
| +1.65% | +3.41% | -1.42% | -14.12% | -14.09% | -12.27% | -7.09% | -40.70% | +7.30% | 12.81B | ||
| +0.13% | +1.75% | -9.28% | -17.51% | -27.84% | -35.08% | -59.56% | -41.74% | -21.24% | 4.7B | ||
| +2.30% | +7.71% | -6.49% | -17.48% | -4.03% | -7.97% | -11.88% | +30.83% | -9.46% | 4.45B | ||
| +2.01% | +5.82% | -0.74% | -5.05% | -14.29% | +16.27% | -12.90% | +39.94% | +128.12% | 3.84B | ||
| +0.65% | +1.44% | -2.03% | -10.85% | -9.49% | +8.96% | -39.86% | -29.08% | +37.68% | 3.8B | ||
| -0.09% | -12.55% | -20.23% | -17.35% | -14.68% | -13.92% | -22.73% | +23.64% | -13.23% | 3.04B | ||
| +1.18% | +1.33% | -4.04% | -5.23% | -8.69% | -12.08% | -5.17% | -7.28% | -45.70% | 3.03B | ||
| +0.80% | +1.27% | -0.85% | -9.75% | -2.94% | -7.04% | -26.27% | -33.36% | - | 2.36B | ||
| +3.25% | +6.45% | -6.49% | -8.36% | -0.43% | -10.89% | +28.39% | +92.17% | +90.22% | 1.71B | ||
| +1.18% | +2.50% | -6.86% | -17.06% | -16.78% | -12.22% | -17.62% | -31.13% | -31.65% | 1.64B | ||
| +1.50% | +2.53% | -4.02% | -9.78% | -8.97% | -8.56% | -40.73% | -9.78% | -37.15% | 1.52B | ||
| -1.25% | +7.00% | +2.08% | -11.24% | -12.07% | -18.80% | +16.38% | +67.77% | +54.46% | 1.45B | ||
| +1.97% | +3.33% | -4.62% | -15.99% | -11.93% | -21.72% | -42.80% | -29.71% | -44.87% | 1.37B | ||
| +2.55% | +2.47% | -5.16% | -12.03% | -8.72% | -10.56% | -28.54% | -7.48% | -29.29% | 1.11B | ||
| +3.83% | +4.90% | +7.96% | +15.62% | +13.06% | +49.08% | +55.94% | -60.45% | +1,935.00% | 1.07B | ||
| +2.11% | +2.20% | -6.64% | -4.57% | -18.08% | -22.73% | -50.29% | -28.82% | -34.96% | 1.04B | ||
| +0.24% | +3.15% | +0.37% | -15.65% | -6.19% | -9.50% | -40.82% | -23.53% | -63.95% | 1.02B | ||
| +2.66% | +5.55% | -6.40% | -19.62% | -22.75% | -30.86% | -60.62% | -68.41% | -30.92% | 1B | ||
| -0.95% | -4.86% | -6.38% | -3.30% | +3.19% | +11.79% | +78.18% | +16.65% | -35.86% | 914M | ||
| Average | +1.29% | +4.63% | -4.27% | -10.49% | -9.78% | -7.80% | -15.16% | -7.39% | +103.03% | 2.59B | |
| Weighted average by Cap. | +1.33% | +4.54% | -4.33% | -12.12% | -11.85% | -9.21% | -17.41% | -11.51% | +47.41% |
- Stock Market
- Stocks
- KGET Stock
- Sector CaliPharms, Inc.
Select your edition
All financial news and data tailored to specific country editions
















